PXN and neoplasm: In contrast to the association with good prognosis observed in the membrane, patients with tumours that expressed high levels of nuclear Lyn or Paxillin (downstream marker of activation) had significantly shorter disease specific survival compared to patient tumours expressing low levels (p = 0.019 & p = 0.028, Fig. 2a-b).